Carbon dioxide (CO2) can be either imported to streams through groundwater and subsurface inputs of soil‐respired CO2 or produced internally through stream metabolism. The contribution of each source to the CO2 evasion flux from streams is not well quantified, especially in the tropics, an underrepresented region in carbon (C) cycling studies. We used high‐frequency measurements of dissolved O2 and CO2 concentrations to estimate the potential contribution of stream metabolism to the CO2 evasion flux in a tropical lowland headwater stream. We found that the stream was heterotrophic all year round, with net ecosystem productivity (NEP) values ranging from 0.84 to 4.06 g C m−2 d−1 (median 1.29 g C m−2 d−1; here we expressed gross primary productivity (GPP) as a negative flux and ecosystem respiration (ER) as a positive flux). Positive NEP values were the result of a relatively low and stable GPP through the seasons, compared to a higher and more variable ER favored by the high temperatures and organic matter availability, particularly during the wet season. The CO2 evasion flux was relatively low due to low turbulence (median: 1.09 g C m−2 d−1). As a result, daily NEP rates exceeded the CO2 evasion flux with a potential contribution of 129% (median; 120–175% interquartile range), despite the strong seasonal changes in flow regime and landscape connectivity. The CO2 excess was likely transported downstream, where it was ultimately emitted to the atmosphere. Our results highlight the overwhelming importance of ER to the C cycle of low‐energy, oligotrophic tropical streams.

IntroductionHistoric disruption in health infrastructure combined with data from a recent vaccine coverage survey suggests there are likely significant immunity gaps to vaccine preventable diseases and high risk of outbreaks in Timor-Leste. Community-based serological surveillance is an important tool to augment understanding of population-level immunity achieved through vaccine coverage and/or derived from prior infection.Methods and analysisThis national population-representative serosurvey will take a three-stage cluster sample and aims to include 5600 individuals above 1 year of age. Serum samples will be collected by phlebotomy and analysed for measles IgG, rubella IgG, SARS-CoV-2 antispike protein IgG, hepatitis B surface antibody and hepatitis B core antigen using commercially available chemiluminescent immunoassays or ELISA. In addition to crude prevalence estimates and to account for differences in Timor-Leste’s age structure, stratified age-standardised prevalence estimates will be calculated, using Asia in 2013 as the standard population. Additionally, this survey will derive a national asset of serum and dried blood spot samples which can be used for further investigation of infectious disease seroepidemiology and/or validation of existing and novel serological assays for infectious diseases.Ethics and disseminationEthical approval has been obtained from the Research Ethics and Technical Committee of the Instituto Nacional da Saúde, Timor-Leste and the Human Research Ethics Committee of the Northern Territory Department of Health and Menzies School of Health Research, Australia. Co-designing this study with Timor-Leste’s Ministry-of-Health and other relevant partner organisations will allow immediate translation of findings into public health policy, which may include changes to routine immunisation service delivery and/or plans for supplementary immunisation activities.

Introduction: Historic disruption in health infrastructure combined with data from a recent vaccine coverage survey suggests there are likely significant immunity gaps to vaccine preventable diseases and high risk of outbreaks in Timor-Leste. Community-based serological surveillance is an important tool to augment understanding of population-level immunity achieved through vaccine coverage and/or derived from prior infection. Methods and analysis: This national population-representative serosurvey will take a three-stage cluster sample and aims to include 5600 individuals above one year of age. Serum samples will be collected by phlebotomy and analysed for measles immunoglobulin G (IgG), rubella IgG, severe acute respiratory syndrome coronavirus-2 anti-spike protein IgG, hepatitis B surface antibody and hepatitis B core antigen using commercially available chemiluminescent immunoassays or enzyme-linked immunosorbent assays. In addition to crude prevalence estimates and to account for differences in Timor-Leste age structure, we will calculate stratified age-standardised prevalence estimates, using Asia in 2013 as the standard population. Additionally, this survey will derive a national asset of serum and dried blood spot samples which can be used for further investigation of infectious disease sero-epidemiology and/or validation of existing and novel serological assays for infectious diseases. Ethics and dissemination: Ethical approval has been obtained from the Research Ethics and Technical Committee of the Instituto Nacional da Saude,Timor-Leste and the Human Research Ethics Committee of the Northern Territory Department of Health and Menzies School of Health Research, Australia. Co-designing this study with Timor-Leste Ministry-of-Health and other relevant partner organisations will allow immediate translation of findings into public health policy (which may include changes to routine immunisation service delivery and/or plans for supplementary immunisation activities).